Connection

Franco Locatelli to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Franco Locatelli has written about Programmed Cell Death 1 Receptor.
Franco Locatelli
Connection Strength
0.184
Programmed Cell Death 1 Receptor
  1. Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma. Sci Rep. 2017 10 25; 7(1):14049.
    View in: PubMed
    Score: 0.122
  2. Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. Front Immunol. 2019; 10:1179.
    View in: PubMed
    Score: 0.034
  3. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. Clin Cancer Res. 2017 Aug 01; 23(15):4462-4472.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.